• Home
  • Resources
  • About
  • Agenda
  • Symposium
  • Login
  • Subscrib
  • Home
  • About
  • Resources
  • Replay
  • Symposium
  • Profile
    • Log out
  • Sign in
    • Subscrib

De-escalation in HER2+ Tumors: What Can Imaging Tell Us?

Paula Borralho
CONTINUE READING

How can AI help us decode multi-Omics data to improve breast cancer treatment?

Aaron HAN
pathologist, Dubai, UAE
CONTINUE READING

How can genomics power personalized medicine through pathology?

Aaron HAN
pathologist, Dubai, UAE
CONTINUE READING

How AI reshaping the future of pathology as we know it?

Aaron HAN
pathologist, Dubai, UAE
CONTINUE READING

AI in pathology and histology monotoring.

Aaron HAN
CONTINUE READING

How can you predict tumor behavior?

Simon NAYLER
pathologist, Johanesburgh, South Africa
CONTINUE READING

At what stage do you integrate liquid biopsy into breast cancer management? How early?

Simon NAYLER
pathologist, Johanesburgh, South Africa
CONTINUE READING

What is the difference between molecular typing and liquid biopsy?

Simon NAYLER
pathologist, Johanesburgh, South Africa
CONTINUE READING
  • 1
  • 2

Copyright © 2026 - BCU

  • Privacy Policy
  • Mentions légales
  • Contact

Our website uses cookies to provide you the best experience. However, by continuing to use our website, you agree to our use of cookies. For more information, read our Cookie Policy.